Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain

BACKGROUND: This study aimed to assess the characteristics of breakthrough cancer pain (BTcP) in patients receiving low doses of opioids for background pain in comparison with patients receiving at least 60 mg of oral morphine equivalents (OME). MATERIALS AND METHODS: Patients with advanced cancer r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Mercadante, Sebastiano, Caraceni, Augusto, Masedu, Francesco, Scipioni, Teresa, Aielli, Federica
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2019
Témata:
Symptom Management and Supportive Care
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011660/
https://ncbi.nlm.nih.gov/pubmed/31862860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0542
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky